Dosing and efficacy of intranasal dexmedetomidine sedation for pediatric transthoracic echocardiography: a retrospective study
Conclusion
We found that aerosolized intranasal dexmedetomidine offers satisfactory conditions for TTE in children three months to three years of age with an optimal dose of 2.5-3.0 µg·kg−1administered under the supervision of a pediatric cardiac anesthesiologist.
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | Children | Heart | Heart Disease | Pediatrics | PET Scan | Study